Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company’s key electrophysiology and cardiac…
Year: 2023
CureScience™ Institute Summer Scholar Bioinformatics Training Program
CureScience™ Institute, a San Diego, California based non-profit 501(c)(3) dedicated to accelerating cures based on a combination of…
Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
Abbott (NYSE: ABT) today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study,…
Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
The “Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The…
Rakuten Medical to Start a Global Phase 3 Trial of Alluminox™ Treatment using ASP-1929 for Recurrent Head and Neck Cancer in India
Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on…
Global Wellness Tourism Market Report 2023: Increasing Spending on Cultural and Sports Tourism Bolsters Growth
The “Wellness Tourism Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and…
Dental Insurance Global Market Report 2023: Increasing Prevalence of Oral Disorders is Expected to Fuel Growth
The “Dental Insurance Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and…
Indivior Announces U.S. Food and Drug Administration Approval of OPVEE® (nalmefene) Nasal Spray, An Opioid Overdose Rescue Medicine for Natural and Synthetic Opioids Like Fentanyl
Indivior PLC (LSE: INDV) today announced that the U.S. Food and Drug Administration (FDA) approved OPVEE® (nalmefene) nasal…
The Rising NAFLD/NASH Epidemic Coupled with High Patient Need Offers Opportunities for Pharmaceutical Manufacturers to Capitalize Across Various Disease Stages, According to Spherix Global Insights
The non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) epidemic is roughly 2.5 times greater than diabetes in…
Marlow Ingredients og Tempty Foods presenterer verdens første samarbeid for bruk av mykoproteinet til Marlow
Storbritannia-baserte Marlow Ingredients (den nyopprettede avdelingen av Marlow Foods), eier av det markedsledende Quorn®-varemerket, har inngått…